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Abstract: 
Whole-genome sequencing projects are a major source of unknown function proteins. However, as predicting protein function from 
sequence remains a difficult task, research groups recently started to use 3D protein structures and structural models to bypass it. MED-
SuMo compares protein surfaces analyzing the composition and spatial distribution of specific chemical groups (hydrogen bond donor, 
acceptor, positive, negative, aromatic, hydrophobic, guanidinium, hydroxyl, acyl and glycine). It is able to recognize proteins that have 
similar binding sites and thus, may perform similar functions. We present here a fine example which points out the interest of MED-
SuMo approach for functional structural annotation.  
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Background: 
The number of available protein sequences has increased 
drastically during the last decade (472 complete genomes have 
been sequenced, http://www.genomesonline.org/). [1] Still, 
about 40% of these sequences are characterized as “unknown 
function”  [2, 3]; they represented more than 3% [2] of the 
Protein DataBank (PDB) structures. [4] 
 
A majority of functional annotation methods relies on sequence 
similarity research, e.g. ProtoNet [5], or characterized sequence 
motifs, e.g. PROSITE. [6] The direct use of 3D structures or 
structural models to assign protein functions is an emerging 
field. This development is due to the increasing number of 
available crystallographic structures, of hypothetical proteins 
obtained by structural genomics consortium [7] and to new 
automatic crystallization methods. The first dedicated methods 
were directly derived from 3D local similarity methods, i.e. local 
rigid superimposition approaches. SuMo was one of the first 
software to use chemical groups description combined with fast 
graph comparison heuristic. [8] SiteEngine, developed later, had 
a comparable approach. [9] ProFunc is a popular web server 
composed of a compendium of structure-based and sequence-
based methods. [10] 
 
Description: 
Recognition of similar binding regions on the protein surface is 
crucial for functional classification and for functional prediction. 
MED-SuMo (http://www.medit.fr/) is able to recognize proteins 
that have similar binding sites and thus may perform similar 
functions. It is an improved version of SuMo (http://sumo-
pbil.ibcp.fr/  [8, 11]) with an updated source code; it is now 
faster and considers an increased amount of natural and 
synthetic ligands. Its heuristic is based on a unique 
representation of macromolecules using selected triplets of 
chemical groups which have their own geometry, regardless of 
the notions of main and lateral chains of amino acids. To extract 
similar sites, MED-SuMo transforms the binding site (or the full 
structure) of a query into a graph in which vertices are triplets of 
chemical group. Then, it is compared to binding sites extracted 
from the PDB which are already pre-assessed and stored in a 
database. [11]  
 
A major drawback in functional annotation is the difficulty to 
identify true “unknown function” proteins. The PDB website 
(http://www.rcsb.org/) associates more than 1,500 structures to 
an “unknown function” annotation. Nevertheless, numerous can 
be annotated using classical approaches (high sequence identity, 
structural homology, residue conservation analysis, sequence 
motifs research, Cleft analysis). As an illustration, 3-keto-L-
gulonate 6-phosphate decarboxylase, a lyase, is represented by 
14 proteins in the PDB. Among this family, 4 structures are 
classified as “unknown function”, but their functions can be 
found in both, the PDB and the reference paper title (e.g. PDB 
code: 1XBX). Moreover, they have significant sequence 
identity/similarity rate and low root mean square deviation 
(rmsd) with 10 other protein structures. 
 
For our study, we have selected proteins from the “Joint Center 
for Structural Genomics” (JCSG, http://www.jcsg.org/); they 
have determined more than 350 protein structures. About half of 
these proteins are classified as “Structural Genomics Unknown 
Function” but most of them share sequence or fold similarity 
with known proteins. Tm1012 is a hypothetical protein from 
Thermotoga maritime (PDB code: 2EWR) and cannot be 
associated to proteins with any known functions. Classical 
approach such as PSI-BLAST [12] launched on the NR database 
(via NCBI web service), or dedicated tool as ProFunc [5] could 
identify neither any related sequence nor any set of residues 
potentially implicated in known interaction or protein function.  
 
As most of these methods, MED-SuMo does not give an all-or-
nothing answer. The results are set out in a hit list, which are 
potentially interesting regions of the protein query, 
superimposed with corresponding similar regions of selected 
targets. Concerning the 2EWR query, the best hit of MED-
SuMo results corresponds to the same protein crystallized by the 
same consortium under different experimental conditions (PDB 
code: 2FCL). The following hits are not directly related to the 
query (not superimposable, nor sharing any significant sequence 
identity, i.e. less than 20%, with 2EWR): 2CJ5, 5APR and 
1OD1. 5APR and 1OD1 have a significant sequence identity 
rate, 38 % with a rmsd of 1.8 Å. Otherwise sequence identity 
rates are less than 22%. Moreover, it is not possible to 
superimpose any of these proteins on more than 20% of their 
length [13], i.e. these proteins are distinct. Bioinformation by Biomedical Informatics Publishing Group                                           open access 
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Figure 1: Examples of MED-SuMo results for hypothetical protein (tm1012) from Thermotoga maritime (in green, PDB code [4]: 
2EWR, crystallized by the Joint Center for Structural Genomics, JCSG, http://www.jcsg.org/). (a) Complete superimposition of 
tm1012 with the cell wall invertase inhibitor from Nicotiana tabacum (in blue, PDB code: 2CJ5), (b) local view of the residues 
superimposed by MED-SuMo, and the ligand acetate ion. (c) Superimposition of tm1012 with rhizopuspepsin (in yellow, PDB code: 
5APR), (d) with the statine ligand. (e) Superimposition of binding site of tm1012 with Endothiapepsin (PDB code: 1OD1), the MED-
SuMo groups are represented; blue: HBond donor, red: HBond acceptor, dark red: Positive, purple: hydroxyl function, light grey: 
hydrophobic 
 
Figure 1 shows two regions of interest for tm1012. The first one 
implicates residues 134, 135 and 138 of tm1012 corresponding 
to residues 17, 18 and 31 of protein 2CJ5 (cell wall invertase 
inhibitor from Nicotiana tabacum). Figure 1a outlines the fact 
that these 2 proteins cannot be globally superimposed and 
Figure 1b displays a closer view of the local superimposition of 
the corresponding residues with the ligand, an acetate ion. Local 
rmsd is less than 0.5 Å and the two regions correspond to the 
same residues (YQ—L). 
 
The second region implicates more residues. Figures 1c and 1d 
show the superimposition of tm1012 and rhizopuspepsin, 5APR. Bioinformation by Biomedical Informatics Publishing Group                                           open access 
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Residues S
76Y
77G
78D
79-S
81 of 5APR and R
99L
100E
101D
102-T
104 of 
tm1012 are superimposed, the same residues are involved for 
1OD1 (see Figure 1e). The local rmsd is quite small even if the 
residues are different. Interestingly only one residue (Aspartate) 
is common, whereas, 9 of the groups used by MED-SuMo 
(hydrophobic, negative, δ
+, δ
-, hydroxyl [8]) to define the ligand 
(statine) site of 5APR and 1OD1, are present in the binding site 
defined by this study for tm1012. Besides, analysis of the 
conservation of the rhizopuspepsin binding site motif shows that 
only 3 out of 5 residues are conserved (QYGT-S), but 8 of the 9 
groups used by MED-SuMo are always present. These results 
show the interest of such an approach. They must be more 
deeply analyzed but gives very interesting insight for further in 
silico and in vivo research that could permit to functionally 
annotate this protein. 
 
Conclusion: 
Classical sequence based approaches make possible to find more 
than half of the protein sequence functions. However, prediction 
of a protein function from its 3D structure is becoming more and 
more important as the worldwide structural genomics initiatives 
continue to solve 3D structures, many of which are unknown 
function proteins. We highlight the interest of MED-SuMo’s 
heuristic, providing an application example, in which MED-
SuMo is able to determine the position of a potential binding site 
of a hypothetical protein whereas other approaches fail. This 
study outlines the potential use of MED-SuMo in annotating 
hypothetical proteinsand for enhanced sequence annotation by 
coupling the MED-SuMo to homology modeling pipelines. 
Besides, the approach may be explored for highlighting 
discrepancies in functional annotation that would be blurred due 
to fold similarities. Future studies will involve a large-scale 
analysis of hypothetical as well as already annotated protein 
structures. 
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